The European Medicines Agency has updated its good clinical practice (GCP) guideline to explain how clinical trial sponsors can demonstrate oversight for activities that are delegated to third-party vendors by written contract.
It builds on earlier advice issued by the EMA with respect to general considerations on how contracting should be addressed....